PatientFi® Announces Study Partnership with Allergan
IRVINE, Calif.--(BUSINESS WIRE)--May 15, 2019--
PatientFi, LLC, a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures, is pleased to announce its partnership with Allergan plc on a year-long market research study to examine the impact of financing plans on patients’ accessibility to aesthetic procedures.
PatientFi has designed a new patient financing program that aligns practice staff to help more patients finance procedures such as breast augmentation, mommy makeovers, and surgical facial rejuvenation. As such, PatientFi is uniquely situated to study patient decision-making factors, including perceived value and affordability.
“PatientFi is excited to partner with Allergan, a world leader in medical aesthetics, and together help gain an understanding of the growth potential of this market by identifying the key financial barriers patients face when considering aesthetic procedures,” says Dr. Louis Bucky, Chairman, PatientFi, LLC. “The rate of innovation in patient financing has not kept pace with the clinical developments of medical aesthetics. We look forward to the results of this market research study.”
Founded by healthcare industry veterans Scott Jorgensen and Todd Watts, PatientFi is solving a number of problems with the patient financing industry today by reducing expensive merchant processing fees and offering patient-friendly financing options delivered via a proprietary, instantaneous credit application and decision process that provides personalized payment plans tailored to each aesthetic patient’s profile and budget.
Allergan commissioned this patient study through PatientFi’s platform because of its innovative approach to increasing access and affordability for patients across the broadest offering of aesthetic procedures. Allergan and PatientFi plan to present their findings in Spring 2020.
About PatientFi ®
Based in Irvine, California, PatientFi, LLC is a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures. The PatientFi platform increases patients’ access to and affordability of aesthetic services and procedures by delivering high approval rates via monthly payment plan packages with instant approvals. With PatientFi, medical practices can now better target and qualify patient leads prior to consultation, increasing the practice’s overall efficiency, patient acceptance rates and profitability.
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry. With colleagues and commercial operations located in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190515005308/en/
CONTACT: PatientFi Media Contact:
Allergan Media Contact:
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: SURGERY TECHNOLOGY OTHER TECHNOLOGY PRACTICE MANAGEMENT HEALTH PHARMACEUTICAL OTHER HEALTH PROFESSIONAL SERVICES FINANCE GENERAL HEALTH
SOURCE: PatientFi, LLC
Copyright Business Wire 2019.
PUB: 05/15/2019 06:00 AM/DISC: 05/15/2019 06:00 AM